• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
20(S)-Ginsenoside Rh2

20(S)-Ginsenoside Rh2

Product ID G3453
Cas No. 78214-33-2
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $134.30 In stock
5 mg $324.90 In stock
10 mg $554.10 In stock
25 mg $1,107.40 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Ginsenoside Rh2 is a triterpene saponin found in Panax and exhibits anticancer chemotherapeutic, anti-metastatic, neuroprotective, cognition enhancing, anti-inflammatory, anti-osteoporotic, antioxidative, and anti-diabetic activities. Ginsenoside Rh2 inhibits aldose reductase and also decreases levels of ROS in keratinocytes. Ginsenoside Rh2 inhibits cell migration, decreases levels of matrix metalloproteinase 3 (MMP3), and increases recruitment of HDAC4 in liver carcinoma cells. In cellular and animal models of glioblastoma, ginsenoside Rh2 inhibits cell and tumor growth. Additionally, ginsenoside Rh2 improves learning and memory by decreasing levels of amyloid-β (Aβ) in animal models of Alzheimer’s disease. In LPS-stimulated macrophages, this compound decreases the release of IL-1β, TNF-α, IL-6, PGE2, and NO and suppresses phosphorylation of p38 MAPK, ERK1/2, JAK, and NF-κB. Ginsenoside Rh2 inhibits osteoclastogenesis by suppressing RANKL-induced osteoclast differentiation in vitro and in vivo. This compound also induces β-cell proliferation by activating Akt and PDX-1, improves glucose tolerance, and increases insulin levels in animal models.

Product Info

Cas No.

78214-33-2

Purity

≥98%

Formula

C36H62O8 H2O

Formula Wt.

640.89

IUPAC Name

(2R,3R,4S,5S,6R)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

Synonym

20S-GinsenosideRh2, 20S-protopanaxdiol-3-O-β-D- glucopyranoside, β-D-Glucopyranoside

Solubility

Soluble in ethanol to 10 mM. Insoluble in water.

Appearance

White Powder

Shipping and Storage

Store Temp

4°C

Ship Temp

Ambient

Downloads

MSDS

G3453 MSDS PDF

Info Sheet

G3453 Info Sheet PDF

References

Fatmawati S, Ersam T, Yu H, et al. 20(S)-Ginsenoside Rh2 as aldose reductase inhibitor from Panax ginseng. Bioorg Med Chem Lett. 2014 Aug 12. [Epub ahead of print]. PMID: 25152999.

Shi Q, Li J, Feng Z, et al. Effect of ginsenoside Rh2 on the migratory ability of HepG2 liver carcinoma cells: Recruiting histone deacetylase and inhibiting activator protein 1 transcription factors. Mol Med Rep. 2014 Jul 18. [Epub ahead of print]. PMID: 25051397.

Li S, Gao Y, Ma W, et al. EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2. Tumour Biol. 2014 Jun;35(6):5593-8. PMID: 24557544.

Qiu J, Li W, Feng SH, et al. Ginsenoside Rh2 promotes nonamyloidgenic cleavage of amyloid precursor protein via a cholesterol-dependent pathway. Genet Mol Res. 2014 May 9;13(2):3586-98. PMID: 24854439.

Yi PF, Bi WY, Shen HQ, et al. Inhibitory effects of sulfated 20(S)-ginsenoside Rh2 on the release of pro-inflammatory mediators in LPS-induced RAW 264.7 cells. Eur J Pharmacol. 2013 Jul 15;712(1-3):60-6. PMID: 23665488.

Choi WY, Lim HW, Lim CJ. Anti-inflammatory, antioxidative and matrix metalloproteinase inhibitory properties of 20(R)-ginsenoside Rh2 in cultured macrophages and keratinocytes. J Pharm Pharmacol. 2013 Feb;65(2):310-6. PMID: 23278699.

He L, Lee J, Jang JH, et al. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos. Bone. 2012 Jun;50(6):1207-13. PMID: 22484180.

Wang Y, Wang H, Liu Y, et al. Antihyperglycemic effect of ginsenoside Rh2 by inducing islet β-cell regeneration in mice. Horm Metab Res. 2012 Jan;44(1):33-40. PMID: 22205570.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • G8101

    Guaifenesin

    Expectorant.

    ≥98%
  • M5756

    Montelukast Sodium

    CysLT1 antagonist.

    ≥98%
  • G1209

    GDC-0980

    PI3K and mTOR inhibitor.

    ≥98%
  • C9710

    Cyclopamine

    Steroidal jerveratrum alkaloid found in Veratru...

    ≥98%
  • V182705

    Verubecestat

    BACE1 inhibitor

    ≥98%
  • T1979

    Tetrahydrocoptisine

    Alkaloid compound originally found in Corydalis...

    ≥98%
  • A491337

    9-Aminocamptothecin Hydrochloride

    Derivative of camptothecin.

    ≥98%
  • V3278

    Vitamin E Acetate

    Vitamin E analog, antioxidant.

    ≥98%
  • T0299

    Tazobactam Sodium

    β-lactamase inhibitor.

    ≥98%
  • F4781

    Fludarabine

    Nucleoside (adenosine) analog; DNA chain termin...

    ≥98%
  • C0250

    Calcitonin Gene Related Peptide II, human

    Calcitonin-family peptide, involved in vasodila...

    ≥95%
  • C0156

    9-Nitro-20S-camptothecin

    Camptothecin derivative; topoisomerase I inhibi...

    ≥98%
  • P3592

    Pixantrone Dimaleate

    Aza-anthracenedione, DNA intercalator; topoisom...

    ≥98%
  • S5753

    Somatostatin-28 (1-14)

    Endogenous neuropeptide hormone; somatostatin a...

    ≥95%
  • B5560

    B-type Natriuretic Peptide (1-32), rat

    Endogenous cardiomodulatory peptide; NPR-A agon...

    ≥95%
  • D183740

    Desoxypipradrol

    NDRI inhibitor

    ≥98%
  • B0026

    Bafilomycin B1

    Macrolide; vacuolar H+-ATPase inhibitor.

    ≥97%
  • R5722

    Rofecoxib

    NSAID; COX-2 inhibitor.

    ≥98%
  • I7155

    Isoindigo

    Potential AhR binding agent.

    ≥98%
  • M1778

    S-(+)-α−Methylbenzyl Isothiocyanate

    ITC, used as chiral agent.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only